logo  
Site Map
Skip Navigation Links

ScreeningDonor Screening

Cryos International - New York donors are physically and mentally healthy men from a broad cross section of society.

Each donor candidate meets a rigorous selection criteria and undergoes a thorough examination prior to acceptance. The donors receive a small remuneration, but it is our belief that they are genuine in their desire to help others. Cryos Interrnational - New York accepts less than 5% of all interested applicants.

Donors are fully informed of the purpose of being a donor. All donors sign a contract declaring that they do not belong to any risk groups or have had any risky behaviour related to exposure to HIV and/or other sexually transmitted diseases. Additionally, all donors waive all paternal rights and responsibilities.

We screen for the following conditions

Communicable Disease & Serological Testing

  • Hepatitis B Surface Antigen
  • Hepatitis B Core Antibody
  • Hepatitis C Antibody
  • HTLV I/II Antibody
  • HIV 1/O/2 Antibody
  • NAT HIV-1; NAT Hepatitis C; NAT Hepatitis B
  • Syphilis
  • Chlamydia
  • Gonorrhea
  • CMV (IgG, IgM)
  • Blood Typing
  • Blood Counts (CBC/Differential/Platelets)

For more information on CMV (Cytomegalovirus), please visit the Department of Health and Human Services Center for Disease Control and Prevention's website at the following link: http://www.cdc.gov/cmv/

Genetic & Chromosome Testing


Prior to July 1, 2012, Cryos NY tested its donors for genetic disorders based on their ethnicity and nationality. Below you will find the genetic and chromosome testing performed prior to July 1, 2012.

  • Cystic Fibrosis - All Donors
  • Sickle Cell Anemia - African Americans
  • Thalassemia - African Americans, Indians, & Descendants of Mediterranean Countries
  • Tay Sachs - Descendants of Eastern Europe, Jewish, & Ashkenazi Jewish
  • Canavan Disease - If donor has increased risk of being a carrier
  • Gaucher Disease - If donor has increased risk of being a carrier
  • Niemann Pick Disease - If donor has increased risk of being a carrier
  • Fanconi Anemia - If donor has increased risk of being a carrier
  • Karyotype (46, XY) - All Donors

After July 1, 2012, Cryos NY performs the below genetic and chormosome testing on all of its donors regardless of ethnicity and nationality.

  • Canavan Disease
  • Cystic Fibrosis
  • Familial Dysautonomia
  • Tay Sachs
  • Bloom Syndrome
  • Fanconi Anemia Type C
  • Gaucher Disease
  • Mucolipidosis IV
  • Niemann Pick Disease
  • Spinal Muscular Atrophy
  • Thalassemia
  • Sickle Cell Disease
  • ABCC8-Related Hyperinsulinism
  • Glycogen Storage Disease Type 1a
  • Hexosaminidase A Deficiency
  • Joubert Syndrome 2
  • Lipoamide Dehydrogenase Deficiency
  • Maple Syrup Urine Disease Type 1B
  • NEB-Related Nemaline Myopathy
  • Usher Syndrome Types 1F and 3
  • Karyotype (46, XY)

As Cryos International - New York supplies donor semen to many countries and as different countries have different approval procedures for donors and semen, the company operates with different Standards. Donors are tested and approved according to at least one Standard, but often more. For instance:

Cryos International - New York is licensed by the following authorities:

  • U.S. Food & Drug Administration
  • New York State Department of Health
  • State of California Department of Public Health
  • State of Maryland Department of Health and Mental Hygiene

To view updated permits and licenses, please click here.

Global Site  Cryos International - New York 90 Maiden Lane, Suite 302 New York, NY 10038 USA +1(866) 366-6777 ny@cryosinternational.com